Clinical Trials Directory

Trials / Sponsors / Kim's Eye Hospital

Kim's Eye Hospital

Academic / Other · 9 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingLong Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization
Age-related Macular Degeneration (ARMD), Choroidal Neovascularization, Anti-vascular Endothelial Growth Factor
Phase 42025-09-23
RecruitingSwitching to Aflibercept 8mg in Patients Showing Limited Response to Previous Treatment
Age-related Macular Degeneration (ARMD)
Phase 42024-10-21
CompletedChoroidal Morphology Changes After Aflibercept Therapy in Pachychoroid Neovasculopathy
Pachychoroid Neovasculopathy
Phase 42022-12-26
CompletedOutcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV
Polypoidal Choroidal Vasculopathy, Choroidal Neovascularization, Age-Related Macular Degeneration
—2022-12-05
UnknownTreat-and-extend Using Aflibercept for Type 3 Neovascularization
Retinal Angiomatous Proliferation
Phase 42021-02-01
CompletedEyes That Do Not Meet the Eligibility Criteria of Clinical Trials on Age-Related Macular Degeneration: Proport
Age-related Macular Degeneration
—2019-08-26
CompletedSelective Retina Therapy With Real-Time Feedback-Controlled Dosimetry for Treating Acute Idiopathic Central Se
Central Serous Chorioretinopathy
N/A2017-01-01
CompletedIntravitreal Aflibercept for Submacular Hemorrhage
Exudative Age-related Macular Degeneration
Phase 42015-12-01
CompletedThe High Cup/Disc Ratio in Children
Glaucoma
—2009-01-01